Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00898937 · ClinicalTrials.gov registry record
Gene Expression in Tumor Tissue From Women Undergoing Surgery for Breast Cancer or Core Biopsy of the Breast
A clinical trial, sponsored by Georgetown University.
- Terminated
- Registry status
- 55
- Enrollment target
NCT00898937: Clinical Trial study, sponsored by Georgetown University.
NCT00898937 is a clinical trial that was terminated before completion, run by Georgetown University. The registered enrollment target is 55 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00898937 was terminated before completion, sponsored by Georgetown University.
- TERMINATED
- Registry status
- 55 participants
- Enrollment target
Study Summary
RATIONALE: Studying samples of breast tissue in the laboratory may help doctors learn more about the genes and proteins found in breast tissue. PURPOSE: This phase I trial is studying genes and proteins in breast tissue from women undergoing surgery for breast cancer or core biopsy of the breast.
Primary Outcome
Concentration of RNA recovered from breast needle biopsies
Interventions
- GENETIC microarray analysis
- PROCEDURE breast biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 1999-09 |
| Est. Completion | 2017-07 |
Why NCT00898937 stopped before completion
NCT00898937 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 55 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which microarray analysis is the first listed.
NCT00898937 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00898937 about?
NCT00898937 is a clinical study titled "Gene Expression in Tumor Tissue From Women Undergoing Surgery for Breast Cancer or Core Biopsy of the Breast". RATIONALE: Studying samples of breast tissue in the laboratory may help doctors learn more about the genes and proteins found in breast tissue. PURPOSE: This phase I trial is studying genes and proteins in breast tissue from women undergoing surgery for breast cancer or core biopsy of the breast.
What is the current status of trial NCT00898937?
This trial is currently terminated. The enrollment target is 55 participants. The study started on 1999-09. Estimated completion is 2017-07.
What interventions are being tested in trial NCT00898937?
The interventions under investigation include: microarray analysis (GENETIC), breast biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT00898937?
This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01638676 · 55 participants · Phase 1
A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
- NCT01906385 · 55 participants · Phase 1
Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)
- NCT03007030 · 55 participants · Phase 2
Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery
- NCT03152058 · 55 participants · Phase 2
IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia